KCA Big Data and Immunotherapeutics Symposium, August 31st, 2018, SydneyMichael Evtushenko
Kids Cancer Alliance warmly invites you to this symposium featuring the latest developments in big data analytics, bioinformatics and, immunotherapeutic targeting.
An all-day symposium on the genomics of childhood cancer and germline predisposition, immune epitope targeting and CAR T cell therapeutics, and, single-cell transcriptomic and proteomic diagnostics in cancer.
For more details please contact Dr Michael Evtushenko MEvtushenko@ccia.unsw.edu.au
The use of genetic engineering technology in animals has been associated with ethical issues, some of which relate to animal welfare. Discuss examples of genetically engineering animals and evaluate the ethical concerns of genetic engineering.
KCA Big Data and Immunotherapeutics Symposium, August 31st, 2018, SydneyMichael Evtushenko
Kids Cancer Alliance warmly invites you to this symposium featuring the latest developments in big data analytics, bioinformatics and, immunotherapeutic targeting.
An all-day symposium on the genomics of childhood cancer and germline predisposition, immune epitope targeting and CAR T cell therapeutics, and, single-cell transcriptomic and proteomic diagnostics in cancer.
For more details please contact Dr Michael Evtushenko MEvtushenko@ccia.unsw.edu.au
The use of genetic engineering technology in animals has been associated with ethical issues, some of which relate to animal welfare. Discuss examples of genetically engineering animals and evaluate the ethical concerns of genetic engineering.
An innovative clinical trail study design _First comprehensive report of impact of genomic alterations, chemotherapy, targeted therapy and immunotherapy on outcomes in the genomics driven squamous master protocol LungMAP.
Introduction to Applications of Proteomics Science,
Proteomics- Techniques, Applications of proteomics
Presented by
A. Harsha Vardhan Naidu
Department of Pharmacology
Metronomic Chemotherapy Vs Best Supportive Care in Progressive Pediatric Tumors.Pranav Sopory
Journaal Club discussing the Randomised Clinical Trial (RCT) of metronomic chemotherapy in extra cranial, non-hematopoietic solid malignancies in paediatric population (aged 5-18 years). Courtesy Dr Atul Batra, Asst. Prof. Medical Oncology, IRCH, AIIMS.
The maturation of genomic technologies has enabled new
discoveries in disease pathogenesis as well as new approaches to patient care.
In pediatric oncology, patients may now receive individualized genomic analysis to identify molecular aberrations of relevance for diagnosis and/or treatment.
Several recent clinical studies have begun to explore the feasibility and utility of genomics-driven precision medicine.
An innovative clinical trail study design _First comprehensive report of impact of genomic alterations, chemotherapy, targeted therapy and immunotherapy on outcomes in the genomics driven squamous master protocol LungMAP.
Introduction to Applications of Proteomics Science,
Proteomics- Techniques, Applications of proteomics
Presented by
A. Harsha Vardhan Naidu
Department of Pharmacology
Metronomic Chemotherapy Vs Best Supportive Care in Progressive Pediatric Tumors.Pranav Sopory
Journaal Club discussing the Randomised Clinical Trial (RCT) of metronomic chemotherapy in extra cranial, non-hematopoietic solid malignancies in paediatric population (aged 5-18 years). Courtesy Dr Atul Batra, Asst. Prof. Medical Oncology, IRCH, AIIMS.
The maturation of genomic technologies has enabled new
discoveries in disease pathogenesis as well as new approaches to patient care.
In pediatric oncology, patients may now receive individualized genomic analysis to identify molecular aberrations of relevance for diagnosis and/or treatment.
Several recent clinical studies have begun to explore the feasibility and utility of genomics-driven precision medicine.
Advances in Childhood Cancer: Big Data & Immunotherapeutics
Friday, 31st August, 2018
Venue: Australian National Maritime Museum, Darling Harbour, Sydney
KCA warmly invites you to this symposium featuring the latest developments in big data analytics, bioinformatics and, immunotherapeutic targeting.
Registration is FREE.
Seating is limited*. To register please email your full name, preferred email address, and name of your primary institution to KCAadmin@ccia.org.au
For more details please contact Dr Michael Evtushenko MEvtushenko@ccia.unsw.edu.au
CHI's Bioassays for Immuno-Oncology Symposium, Oct. 23, 2017 in Washington, DCJames Prudhomme
Biological assays demonstrating drug characteristics such as potency, mechanism-of-action, and stability, are one of the most critical components of an FDA biologic submission. However, with more complex mechanisms-of-action, immunotherapies add a layer of difficulty to bioassay selection and development. At Cambridge Healthtech Institute's Inaugural Bioassays for Immuno-Oncology symposium, experts in bioassays for immuno-oncology therapies will discuss selection, development, and standards for bioassays and immunoassays. Special attention will be given to understanding the mechanism-of-action for immunotherapies, whether they be antibody- or cell-based. Overall, this one-day immersive symposium will outline a product life cycle approach for developing and implementing biological assays from preclinical studies to clinical development. This symposium is part of the Immunogenicity & Bioassay Summit.
38 experts on bpa panel consensus statement. effects in animals and potential...ricguer
Un conjunto de 38 prestigiados científicos de todo el mundo alertan sobre el potencial nocivo y los impactos de exposición al Bisphenol A para la salud humana.
1. WANG LAN-GE
Tel: +44 (0)772 088 9830 E-mail: lange.wang@postgrad.manchester.ac.uk
Address: No. 25, Trinity Court, 44 Higher Cambridge Street, Manchester M15 6AR, UK
Education Background
Since 09/2011 Faculty of Life Sciences, University of Manchester
Major: Molecular Cancer Studies Degree: PhD (expected)
09/2008-07/2011 Department of Biochemistry and Molecular Biology, School of Basic Medicine,
Capital Medical University
Major: Molecular Biology Degree: Master of Science
09/2004-06/2008 School of Pharmaceutical Sciences, Capital Medical University
Major: Pharmacy Degree: Bachelor of Science
Working and Internship Experience
Since 09/2014 Suman Education International Interpreter
A professional English-Chinese oral and written translator for GCSE&A Level chemistry, physics and
biology lectures
02/2013-10/2014 Faculty of Life Sciences, University of Manchester Demonstrator
A demonstrator of biochemistry, molecular biology, genetics and pharmacology & physiology course
(laboratory module) for undergraduates
09/2009-01/2010 Department of Biochemistry and Molecular Biology, School of Medical Sciences,
Capital Medical University Teacher
Biochemistry course (laboratory module) teacher for undergraduates
07/2008-08/2008 Chinese Federation of Corporate Social Responsibility Intern
Participated in preparation of the reconstruction project after the great earthquake in Fangbei
Village, An County, Sichuan Province
Collected the literatures and reference data about corporate credit rating to establish “CFCSR 50
Index” (an investment index of listed corporate socialresponsibility)
07/2007-08/2007 Department of Chemical Drugs
National Institutes for Food and Drug Control Intern
Assisted scientists in chemical drugs inspection
Learned about methods and protocol of chemical drugs inspection based on the pharmacopoeia
10/2004-02/2006 EAA English Association, Capital Medical University Manager
“Watching Films and Learning English” project manager
2005 and 2006 EAA New Year’s Ball co-organiser
01/2005-02/2005 Beijing Children Hospital Volunteer
An assistant at the department of radiation and the clinical laboratory
ResearchExperience
03/2015 Attending Keystone Symposia conference - DNA replication and recombination &
Genomic instability and DNA repair (joint with) in Whistler, Canada (Poster No. X4
3048: MicroRNAs fine-tune p53-Mdm2 dynamics at single cell level)
2. Since 09/2011 The regulation of p53-Mdm2 dynamics by miRNAs at single-cell level
Supervisor: Dean Jackson, Faculty of Life Sciences, University of Manchester
09/2008-06/2011 Investigation of genes co-regulated by Notch-1 intra-cellular domain and CBF-1 at
transcription level in the whole genome of human pancreatic cancer cell line BxPC3
(published on Journal of Capital Medical University)
The Tyrosine Kinase c-Src Directly Mediates Growth Factor-Induced Notch-1 and
Furin Interaction and Notch-1 Activation in Pancreatic Cancer Cells (published on
PLoS One in 2012)
TGF-α induces proliferation of human pancreatic adenocarcinoma cells by
up-regulation the level and transcription activity of Notch-1 intra-cellular domain
Supervisor: Yuxiang Zhang, Department of Biochemistry and Molecular Biology, School
of Basic Medicine, Capital Medical University
10/2007-05/2008 Effect of lycopene on cerebral ischemia of rats and the protection on mitochondria
(published on Chinese Journal of New Drugs in 2012)
Supervisor: Jie Xiong, Department of Pharmacology, School of Basic Medicine, Capital
Medical University
06/2005-02/2007 A study on synthetic methods of polypeptide heterocyclic Compounds with
Thrombolytic Activity
Supervisor: Feng Zhang, Department of Pharmacochemistry, School of Pharmaceutical
Sciences, Capital Medical University
Papers
Investigation of genes co-regulated by Notch-1 intra-cellular domain and CBF-1 at transcription
level in the whole genome of human pancreatic cancer cell line BxPC3. Journal of Capital Medical
University, 2014, 35(2): 237-242
The Tyrosine Kinase c-Src Directly Mediates Growth Factor-Induced Notch-1 and Furin
Interaction and Notch-1 Activation in Pancreatic Cancer Cells. PLoS One, 2012, 7(3):e33414
TGF-α induces proliferation of human pancreatic adenocarcinoma cells by up-regulation the
level and transcription activity of Notch-1 intra-cellular domain (an unpublished working paper)
Effect of lycopene on cerebral ischemia of rats and the protection on mitochondria. Chinese
Journal of New Drugs, 2012, 21(04): 423-427
A study on synthetic methods of polypeptide heterocyclic compounds with thrombolytic activity
(an unpublished working paper)